The Effects of Interferon-gamma on Sepsis-induced Immunoparalysis

PHASE3CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
SepsisSeptic Shock
Interventions
DRUG

Interferon-gamma, Recombinant

Interferon-gamma (Immukine, Boehringer-Ingelheim, Alkmaar, the Netherlands), 100mcg subcutaneously, on days 0-2-4-7-9-11. Interferon-gamma treatment will be initiated when the noradrenalin dose is reduced to 50% of maximum dose, ensuring that the sepsis-induced pro-inflammatory phase has passed

OTHER

Saline 0.9%

subcutaneous administration on days 0, 2, 4, 7, 9, and 11.

Trial Locations (1)

Unknown

Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT01649921 - The Effects of Interferon-gamma on Sepsis-induced Immunoparalysis | Biotech Hunter | Biotech Hunter